529 related articles for article (PubMed ID: 15763649)
1. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
Taylor RE; Bailey CC; Robinson KJ; Weston CL; Walker DA; Ellison D; Ironside J; Pizer BL; Lashford LS
Eur J Cancer; 2005 Mar; 41(5):727-34. PubMed ID: 15763649
[TBL] [Abstract][Full Text] [Related]
2. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
Taylor RE; Bailey CC; Robinson KJ; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Saran F; Walker DA; Pizer BL; Lashford LS; ;
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1184-93. PubMed ID: 15001263
[TBL] [Abstract][Full Text] [Related]
3. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
[TBL] [Abstract][Full Text] [Related]
4. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
[TBL] [Abstract][Full Text] [Related]
5. [High-dose chemotherapy in relapse of medulloblastoma in young children].
Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
Bull Cancer; 1997 Mar; 84(3):264-72. PubMed ID: 9207872
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
[TBL] [Abstract][Full Text] [Related]
7. Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study.
Verlooy J; Mosseri V; Bracard S; Tubiana AL; Kalifa C; Pichon F; Frappaz D; Chastagner P; Pagnier A; Bertozzi AI; Gentet JC; Sariban E; Rialland X; Edan C; Bours D; Zerah M; Le Gales C; Alapetite C; Doz F
Eur J Cancer; 2006 Nov; 42(17):3004-14. PubMed ID: 16956759
[TBL] [Abstract][Full Text] [Related]
8. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.
Taylor RE; Bailey CC; Robinson K; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Walker DA; Pizer BL; Imeson J; Lashford LS; ;
J Clin Oncol; 2003 Apr; 21(8):1581-91. PubMed ID: 12697884
[TBL] [Abstract][Full Text] [Related]
9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
10. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.
Dhall G; Grodman H; Ji L; Sands S; Gardner S; Dunkel IJ; McCowage GB; Diez B; Allen JC; Gopalan A; Cornelius AS; Termuhlen A; Abromowitch M; Sposto R; Finlay JL
Pediatr Blood Cancer; 2008 Jun; 50(6):1169-75. PubMed ID: 18293379
[TBL] [Abstract][Full Text] [Related]
11. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
Massimino M; Gandola L; Spreafico F; Luksch R; Collini P; Giangaspero F; Simonetti F; Casanova M; Cefalo G; Pignoli E; Ferrari A; Terenziani M; Podda M; Meazza C; Polastri D; Poggi G; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1031-7. PubMed ID: 16343801
[TBL] [Abstract][Full Text] [Related]
12. Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study.
Pizer BL; Weston CL; Robinson KJ; Ellison DW; Ironside J; Saran F; Lashford LS; Tait D; Lucraft H; Walker DA; Bailey CC; Taylor RE
Eur J Cancer; 2006 May; 42(8):1120-8. PubMed ID: 16632346
[TBL] [Abstract][Full Text] [Related]
13. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
[TBL] [Abstract][Full Text] [Related]
14. Timing of radiation in children with medulloblastoma/PNET.
Santos MA; Viégas CM; Servidoni RA; Barros MH; Pinel MI; Araújo CM
Pediatr Blood Cancer; 2007 Apr; 48(4):416-22. PubMed ID: 17034032
[TBL] [Abstract][Full Text] [Related]
15. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
[TBL] [Abstract][Full Text] [Related]
16. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
Ridola V; Grill J; Doz F; Gentet JC; Frappaz D; Raquin MA; Habrand JL; Sainte-Rose C; Valteau-Couanet D; Kalifa C
Cancer; 2007 Jul; 110(1):156-63. PubMed ID: 17541945
[TBL] [Abstract][Full Text] [Related]
18. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
Rutkowski S; Gerber NU; von Hoff K; Gnekow A; Bode U; Graf N; Berthold F; Henze G; Wolff JE; Warmuth-Metz M; Soerensen N; Emser A; Ottensmeier H; Deinlein F; Schlegel PG; Kortmann RD; Pietsch T; Kuehl J;
Neuro Oncol; 2009 Apr; 11(2):201-10. PubMed ID: 18818397
[TBL] [Abstract][Full Text] [Related]
19. Survival of adults treated for medulloblastoma using paediatric protocols.
Spreafico F; Massimino M; Gandola L; Cefalo G; Mazza E; Landonio G; Pignoli E; Poggi G; Terenziani M; Pedrazzoli P; Siena S; Fossati-Bellani F
Eur J Cancer; 2005 Jun; 41(9):1304-10. PubMed ID: 15869875
[TBL] [Abstract][Full Text] [Related]
20. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
Kellie SJ; Wong CK; Pozza LD; Waters KD; Lockwood L; Mauger DC; White L
Med Pediatr Oncol; 2002 Sep; 39(3):168-74. PubMed ID: 12210445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]